Eppendorf continues on course for growth

Increased market share in Asia

06-Jun-2011 - Germany

In the Life Science markets conditions improved with the economic recovery in the Financial Year 2010. While many companies made up their losses from the previous year which were due to the economic crisis, Eppendorf was able to consolidate its market position again during the reporting year. Eppendorf achieved a continued positive development of its performance.

The sales of the Eppendorf group increased to 484 million Euros in 2010, surpassing sales in the previous year by 11.7 percent (433,2 million Euros in the previous year).

International growth was mixed in the reporting year. While Asia showed the strongest growth with 19.9 percent, North America grew by 10.9 percent and, Europe exceeded previous year's sales by 8.4 percent.

Eppendorf AG completes conversion to European public limited company

Group headquarter remains in Hamburg, Germany

Read news

There was a pleasant increase in earnings before interest and taxes by 20.1 percent from 77.9 million to 93.6 million Euros. The profit margin increased from 18.0 percent in 2009 to 19.4 percent in the reporting period. Annual profits were up by 20.8 percent and reached 59.3 million Euros (49.1 million Euros in the previous year).

The financial statement of the Eppendorf group confirms its extremely solid structure of the previous years and shows yet another improvement with an equity ratio of more than 58 percent in 2010 (55.3 percent in the previous year).

At the end of 2010, the Eppendorf group employed a total of 2622 people (2502 employees in the previous year).

"After the upheaval of the economic crisis of 2009 the economy was not yet back on solid footing in 2010. In spite of this, Eppendorf can look back on a successful year based on strong growth in Asia and the recovery of the European and US economies", comments Klaus Fink, CEO of Eppendorf AG who will swap the Chair of the Executive Board with the Chair of the Supervisory Board on May 1, 2011. On the same day, Dr. Dirk Ehlers will succeed him as CEO.

Eppendorf has an optimistic outlook for the future and expects a positive development in the current financial year 2011, with further growth in sales and earnings.

https://www.analytica-world.com/en/news/132810/eppendorf-continues-on-course-for-growth.html